P14.06 Phase II randomized trial of short course hypofractionated radiotherapy with or without temozolomide in elderly patients with Glioblastoma

BACKGROUND: Glioblastoma (GBM) is the most aggressive primary brain tumor. Although treatment advances and introduction of temozolomide has improved the outcome in young patients, it is still a concern in elderly patients. Elderly population is often excluded from the trials, thus established treatm...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuro Oncol
Главные авторы: Madan, R, Thakur, S, Salunke, P, Ahuja, C, Khosla, D, Yadav, B S, Kapoor, R, Kumar, N
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2019
Предметы:
Poster Presentations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6795944/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.242
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы